PUBLISHER: The Business Research Company | PRODUCT CODE: 1946572
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946572
Multiplex PCR assays are advanced polymerase chain reaction techniques designed to simultaneously amplify and detect multiple DNA or RNA targets within a single reaction. This approach significantly enhances efficiency by enabling the analysis of various genetic markers or pathogens concurrently, offering comprehensive and cost-effective results.
The primary types of multiplex PCR assays include planar assays and bead-based assays. Planar assays are conducted on flat surfaces or platforms, such as microplates or slides, where arrays of probes are affixed to detect multiple targets in a single sample, facilitating efficient and high-throughput analysis. The product and service offerings encompass consumables, instruments, software, and services applicable to disease diagnosis, research and development, among other areas. End users of these technologies include biopharmaceutical companies, clinical research organizations, academic research institutes, and diagnostic centers.
Tariffs have influenced the multiplex pcr assays market by increasing costs for imported reagents, enzymes, consumables, and analytical instruments. These impacts are most evident in north america and asia-pacific, where laboratories depend heavily on globally sourced molecular diagnostics components. Elevated costs have affected pricing and procurement decisions for diagnostic centers and research institutes. On the positive side, tariffs have encouraged local manufacturing, regional reagent production, and supply chain diversification, strengthening long-term market resilience.
The multiplex pcr assays market research report is one of a series of new reports from The Business Research Company that provides multiplex pcr assays market statistics, including multiplex pcr assays industry global market size, regional shares, competitors with a multiplex pcr assays market share, detailed multiplex pcr assays market segments, market trends and opportunities, and any further data you may need to thrive in the multiplex pcr assays industry. This multiplex pcr assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The multiplex pcr assays market size has grown rapidly in recent years. It will grow from $1.7 billion in 2025 to $1.93 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to rising burden of infectious diseases, increasing adoption of molecular diagnostics, limitations of singleplex pcr testing, growing demand for rapid diagnostic results, expansion of diagnostic laboratory infrastructure.
The multiplex pcr assays market size is expected to see rapid growth in the next few years. It will grow to $3.17 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to growing focus on early disease detection, rising demand for comprehensive diagnostic solutions, expansion of personalized medicine approaches, increasing investments in molecular diagnostics, growing adoption of multiplex assays in routine testing. Major trends in the forecast period include rising adoption of multiplex testing for infectious diseases, increasing demand for high-throughput diagnostic assays, growing use of syndromic testing panels, expansion of multiplex pcr in clinical diagnostics, increasing preference for cost-effective multi-target assays.
The growing demand for diagnostic testing is projected to drive the expansion of the multiplex PCR assay market. Diagnostic testing encompasses procedures or tests used to determine the presence or absence of diseases or conditions in patients. The increasing prevalence of chronic illnesses, such as cancer and diabetes, necessitates early and precise diagnosis for effective management. Furthermore, the emphasis on preventive healthcare promotes routine testing to identify potential health issues early. Multiplex PCR assays enable the simultaneous detection and analysis of multiple pathogens or genetic markers from a single sample, thereby enhancing the efficiency and thoroughness of diagnostic testing. For example, in July 2024, the National Health Service (NHS) reported that diagnostic activity surpassed pre-pandemic levels in 2023, with a 21% rise in tests conducted in May 2024 compared to the previous year. Additionally, 2.4 million diagnostic tests were performed in May 2024. This rising demand for diagnostic testing is expected to drive the growth of the multiplex PCR assay market.
Key players in the multiplex PCR assays market are focusing on integrating automation, such as next-generation quantitative PCR (qPCR) systems, to enhance precise and flexible nucleic acid quantification for advanced clinical diagnostics and public health. Next-generation qPCR systems provide high-throughput, accurate, and simultaneous detection of multiple targets, thus improving diagnostic accuracy and efficiency. For instance, in November 2023, Roche Diagnostics Corporation, a Swiss-based diagnostic system solutions provider, introduced the LightCycler PRO System. This next-generation qPCR platform offers high-throughput, precise, and simultaneous detection of multiple targets, featuring improved temperature uniformity, advanced software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays. This launch exemplifies the incorporation of automation in the multiplex PCR assays market, advancing clinical diagnostics and public health.
In July 2023, QIAGEN N.V., a Germany-based biotechnology company, partnered with Niba Labs. This partnership aims to advance research in genomic testing and personalized medicine by providing cutting-edge tools, data analysis, and expertise to foster innovation in biotechnology and healthcare. Niba Labs, a US-based biotechnology company, specializes in developing and manufacturing products for genomic research, molecular diagnostics, and personalized medicine.
Major companies operating in the multiplex pcr assays market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc, PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN NV, Tecan Group Ltd, DiaSorin SpA, Bio-Techne Corporation, Promega Corporation, Randox Laboratories Ltd, BioFire Diagnostics Inc, Seegene Inc, NanoString Technologies, Standard BioTools Inc, Agena Bioscience, Fluidigm Corporation
North America was the largest region in the multiplex PCR assays market in 2025. The regions covered in the multiplex pcr assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the multiplex pcr assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The multiplex PCR assays market consists of sales of reverse transcription multiplex PCR (RT-multiplex PCR), digital multiplex PCR, end-point multiplex PCR, multiplex ligation-dependent probe amplification (MLPA), and probe-based multiplex PCR. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Multiplex PCR Assays Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses multiplex pcr assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for multiplex pcr assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The multiplex pcr assays market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.